Xylazine and other Toxic Adulterants

Enroll Yourself

Pharmacologically active compounds, impurities, or breakdown products from drug manufacturing and industrial chemicals (collectively referred to as toxic adulterants) have been increasing detected in illicit drug supply around the world. This training activity will discuss the increasing prevalence and dangers of toxic adulterants in the illicit drug supply. The training will focus discuss the prevalence of various toxic adulterants but, will focus on the dangers of the most- commonly-detected adulterant, xylazine (aka "tranq"). The training will include the most up-to-date evidence and information regarding xylazine's clinical effects, health impacts and complications associated with its' chronic use and review the most current recommendations for providers to detect and treat xylazine exposure.

Objectives:

• Describe the pharmacology of xylazine.
• Review the epidemiology, trends and increasing prevalence of toxic adulterants in the illicit drug supply.
• Recognize the frequent indicators, signs and symptoms and treatment of xylazine toxicity, overdose, and withdrawal.
• Discuss the most common clinical effects, health impacts and complications associated with xylazine use.
• Discuss appropriate patient education and harm reduction strategies associated with xylazine exposure and other adulterants.

This event is subject to priority registration. If you have a code, you may register yourself now. If you do not have a registration code, please add yourself to the waitlist. Any registration spots avilable after the priority registration period is over will be awarded on a first-come first-served basis for those on the waitlist.

Fee Breakdown

Category	Description	Amount
Course Fee (Basic)	Zoom - No Charge	$ 0.00